11 Jan 2021 | 10:23 am | 1 min. read
Multinational law firm Pinsent Masons advised GNA Biosolutions GmbH on IP and commercial aspects of its rapid PCR Covid-19 test.
The test, developed by German molecular diagnostics company GNA Biosolutions, has been approved by the domestic regulatory German Federal Institute for Drugs and Medical Devices (BfArM). The new PCR test, which produces a result in 40 minutes, is being rolled out across Germany with EU-wide approval expected in the coming months
The reliability of the rapid test system by GNA Biosolutions is comparable to common PCR tests, which, however, require up to 48 hours for a result.
The Pinsent Masons team advising on the deal was led by corporate partner Tobias Rodehau and included head of German public and regulatory Dr. Anke Empting, commercial and IP partner Dr. Michael Reich, technology, science and industry sector head Dr. Florian von Baum, head of German IP Marc Holtorf, and commercial legal director Dr. Igor Barabash.
Commenting on the project, Tobias Rodehau, said: "We are proud to have been able to assist GNA Biosolutions GmbH with this important project. Thanks to our expertise in the life sciences sector, we are familiar with the specifics of this industry and have been able to assemble a cross disciplinary team to play a role in facilitating swift access to this groundbreaking technology."
GNA Biosolutions GmbH is a long-standing client of Pinsent Masons. In 2019 the firm successfully advised the company on its USD 13.5 million Series C financing.
The Bavarian state government has acquired six GNA Biosolutions test devices, which were officially approved in December, as well as 60,000 test kits.
Rechtsanwalt, Partner
Tobias specialises in small and mid-cap private equity transactions, with a focus on venture capital transactions.
Rechtsanwalt, Partner, Sector Head Technology, Science & Industry
Florian is the Global Head of Technology, Science & Industry
Rechtsanwalt, Partner, Head of German Life Sciences
Marc is Deputy Head of Pinsent Masons Germany. He also heads the German Life Sciences team. He specialises in supporting pharmaceutical, medical device and other high-tech companies in navigating through the complex world of contentious and non-contentious intellectual property.
Key Contacts
Multinational law firm Pinsent Masons has today announced its latest round of partner promotions, with 24 set to join its global partnership on 1 May.
Multinational law firm Pinsent Masons has advised Azets Ireland on the merger with Cooney Carey, combining two of Ireland’s leading accountancy, tax and business advisory firms.
Multinational law firm Pinsent Masons has today announced the hire of Dr. Sairah Narmah-Alqasim to head up the employment practice for its newly launched Riyadh office in the Kingdom of Saudi Arabia (KSA).
Multinational law firm Pinsent Masons has advised Australian heavy machinery manufacturer Elphinstone Group on its proposed takeover bid for Engenco Limited, a provider of sustainable transportation products.
Multinational law firm Pinsent Masons has advised Fintech Asia Limited, a publicly listed company on the mainboard of the London Stock Exchange, in a reverse takeover of ICFG Pte. Ltd.
Multinational law firm Pinsent Masons has advised R.R. Donnelley & Sons Company (RRD) on its acquisition of business support services provider Williams Lea from private equity investor, Advent.
For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on
Location contacts
Europe: [email protected]
Asia: [email protected]
Middle East: [email protected]
Australia: [email protected]